Virtu Financial’s Aldeyra Therapeutics ALDX Stock Holding History

Virtu Financial’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34K	Buy	+15,826	New	+$27.2K	﹤0.01%	1281
2023 Q3	–	Sell	-49,294	Closed	-$414K	–	1246
2023 Q2	$414K	Buy	+49,294	New	+$486K	0.03%	464
2022 Q4	–	Sell	-18,573	Closed	-$99K	–	1547
2022 Q3	$99K	Buy	+18,573	New	+$111K	0.01%	1085
2022 Q1	–	Sell	-32,401	Closed	-$130K	–	1459
2021 Q4	$130K	Buy	+32,401	New	+$247K	0.01%	1014
2021 Q3	–	Sell	-12,824	Closed	-$145K	–	1454
2021 Q2	$145K	Buy	+12,824	New	+$154K	0.01%	1105
2021 Q1	–	Sell	-13,428	Closed	-$92K	–	1557
2020 Q4	$92K	Sell	13,428 -14,896	-53%	-$105K	0.01%	1082
2020 Q3	$210K	Buy	+28,324	New	+$183K	0.04%	581
2019 Q4	$92K	Buy	+15,886	New	+$91.8K	0.01%	1097
2019 Q3	–	Sell	-15,932	Closed	-$96K	–	1399
2019 Q2	$96K	Buy	+15,932	New	+$120K	0.01%	1137
2018 Q4	–	Sell	-73,023	Closed	-$1.01M	–	1519
2018 Q3	$1.01M	Buy	73,023 +59,955	+459%	+$486K	0.06%	327
2018 Q2	$104K	Buy	+13,068	New	+$104K	0.01%	1637

Other funds holding ALDX

KCM

Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Virtu Financial's ALDX Position: Q2 2026 in Review

Virtu Financial opened a new position in Aldeyra Therapeutics (ALDX) in Q2 2026: 15,826 shares worth $34K. The stake represents ﹤0.01% of the portfolio and ranks #1281 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ALDX as recently as Q2 2023.

Virtu Financial first reported a position in ALDX in Q2 2018 and has held it in 11 quarters since. The position peaked at $1.01M in Q3 2018. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

Virtu Financial held 15,826 shares of Aldeyra Therapeutics worth $34K as of Q2 2026.
Aldeyra Therapeutics was a new Virtu Financial position in Q2 2026.
Aldeyra Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1281 holding.
Virtu Financial first reported a position in Aldeyra Therapeutics in Q2 2018 and has held it in 11 quarters since.
Virtu Financial's Aldeyra Therapeutics position peaked at $1.01M in Q3 2018.
107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.